Xcelience Opens New Headquarters

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-11-04-2015
Volume 11
Issue 11

CDMO Xcelience opens new facility in Tampa, FL, for formulation and analytical services.

Xcelience opened a 71,000-sq-ft headquarters facility in Tampa, FL on Oct. 30, 2015.

Xcelience, a contract development and manufacturer (CDMO), has announced the opening of a new 71,000-sq-ft headquarters at 4910 Savarese Circle in Tampa, FL.  The building houses preformulation and formulation development labs and suites, executive headquarters, and analytical and stability services.  An official ribbon cutting ceremony on Oct. 30, 2015 was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn, and other elected and non-elected officials. 

The company’s previous headquarters on West Laurel Street in Tampa will transition to provide clinical trial and small-scale commercial manufacturing. 

In July 2015, Xcelience made a structured cash investment in Powdersize, a Pennsylvania-based company specializing in milling, micronization, and powder size, adding particle size control solutions to Xcelience’s portfolio of capabilities.

Xcelience provides services from preformulation through global clinical supplies packaging and distribution to international pharmaceutical and biotechnology clients for Phases I-IV.  Since its inception in 2006, the company has grown from one facility with 45 employees to an international CDMO provider, with seven facilities and more than 200 employees.

Source: Xcelience

 

 

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content